Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17138065 | COMPUTATIONAL REDUCTION VACCINE FOR COVID-19 BIN100 | December 2020 | June 2024 | Allow | 42 | 1 | 1 | Yes | No |
| 16973731 | VACCINATION AGAINST PORCINE CIRCOVIRUSES | December 2020 | October 2023 | Allow | 34 | 2 | 0 | No | No |
| 17058020 | Bacteriophage Compositions and Kits and Related Methods | November 2020 | January 2024 | Allow | 38 | 2 | 2 | No | No |
| 17051019 | MULTIANALYTE IMMUNOASSAY FOR ZIKA VIRUS AND USES THEREOF | October 2020 | July 2023 | Abandon | 33 | 0 | 1 | No | No |
| 16971761 | HUMAN JAPANESE ENCEPHALITIS VIRUS ANTIBODIES AND METHODS OF USE THEREFOR | August 2020 | December 2023 | Allow | 40 | 1 | 1 | Yes | No |
| 16966588 | EFFICIENT INFECTION OF PRIMARY KERATINOCYTES BY HPV16 | July 2020 | April 2024 | Abandon | 44 | 1 | 0 | No | No |
| 16966248 | Binding Molecule Having Neutralizing Activity Against Middle East Respiratory Syndrome-Coronavirus | July 2020 | July 2023 | Abandon | 35 | 0 | 1 | No | No |
| 16965549 | GROUP B ADENOVIRUS-CONTAINING FORMULATION | July 2020 | January 2024 | Allow | 42 | 1 | 0 | Yes | No |
| 16961609 | EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 6A | July 2020 | March 2024 | Allow | 44 | 1 | 0 | Yes | No |
| 16753322 | GENE THERAPIES FOR LYSOSOMAL DISORDERS | April 2020 | January 2024 | Allow | 45 | 0 | 1 | No | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner SIFFORD, JEFFREY MARK works in Art Unit 1648 and has examined 10 patent applications in our dataset. With an allowance rate of 70.0%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 42 months.
Examiner SIFFORD, JEFFREY MARK's allowance rate of 70.0% places them in the 33% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by SIFFORD, JEFFREY MARK receive 0.90 office actions before reaching final disposition. This places the examiner in the 5% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by SIFFORD, JEFFREY MARK is 42 months. This places the examiner in the 18% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +50.0% benefit to allowance rate for applications examined by SIFFORD, JEFFREY MARK. This interview benefit is in the 92% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 50.0% of applications are subsequently allowed. This success rate is in the 96% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 100.0% of cases where such amendments are filed. This entry rate is in the 98% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.